Iron Gate Global Advisors’s GSK GSK Stock Holding History

Iron Gate Global Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$300K	Buy	+5,429	New	+$294K	0.03%	78
2020 Q3	–	Sell	-4,091	Closed	-$209K	–	103
2020 Q2	$209K	Buy	+4,091	New	+$210K	0.1%	79
2020 Q1	–	Sell	-3,680	Closed	-$216K	–	59
2019 Q4	$216K	Buy	+3,680	New	+$205K	0.12%	59
2018 Q4	–	Sell	-3,200	Closed	-$161K	–	136
2018 Q3	$161K	Sell	3,200 -640	-17%	-$32.5K	0.1%	67
2018 Q2	$193K	Buy	+3,840	New	+$193K	0.14%	48
2018 Q1	–	Sell	-3,200	Closed	-$141K	–	60
2017 Q4	$141K	Buy	+3,200	New	+$148K	0.12%	47

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Iron Gate Global Advisors's GSK Position: Q1 2026 in Review

Iron Gate Global Advisors opened a new position in GSK (GSK) in Q1 2026: 5,429 shares worth $300K. The stake represents 0.03% of the portfolio and ranks #78 among its holdings. This is a return to the name: Iron Gate Global Advisors previously reported a position in GSK as recently as Q2 2020.

Iron Gate Global Advisors first reported a position in GSK in Q4 2017 and has held it in 6 quarters since. 1,032 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

Iron Gate Global Advisors held 5,429 shares of GSK worth $300K as of Q1 2026.
GSK was a new Iron Gate Global Advisors position in Q1 2026.
GSK made up 0.03% of Iron Gate Global Advisors's portfolio in Q1 2026, its #78 holding.
Iron Gate Global Advisors first reported a position in GSK in Q4 2017 and has held it in 6 quarters since.
1,032 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Iron Gate Global Advisors's 13F filing for Q1 2026, filed 15 May 2026.